PKR protein kinase is activated by hepatitis C virus and inhibits viral replication through translational control

Virus Research

Volumn 142, Issue 1-2, 2009, Pages 51-56

  Kang, Ju Il ^a   Kwon, Shi Nae ^a   Park, Se Hoon ^a   Kim, Yun Ki ^a   Choi, Sang Yun ^a   Kim, Jungsuh P ^a   Ahn, Byung Yoon ^a  

^a Korea University   (South Korea)

Author keywords

eIF2 phosphorylation; Hepatitis C virus; Interferon; JFH1; PKR; Translational control

Indexed keywords

INITIATION FACTOR 2ALPHA; INTERFERON; INTERFERON INDUCIBLE PROTEIN KINASE; MUTANT PROTEIN; PROTEIN KINASE; PROTEIN PKR; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; VIRUS INHIBITION; VIRUS REPLICATION;

CELL LINE; EIF-2 KINASE; EUKARYOTIC INITIATION FACTOR-2; HEPACIVIRUS; HEPATITIS C; HUMANS; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; TRANSCRIPTIONAL ACTIVATION; VIRAL PROTEINS; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 67349265228     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2009.01.007     Document Type: Article

References (33)

1. Balachandran S., Roberts P.C., Brown L.E., Truong H., Pattnaik A.K., Archer D.R., and Barber G.N. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13 1 (2000) 129-141
2. Bigger C.B., Brasky K.M., and Lanford R.E. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J. Virol. 75 15 (2001) 7059-7066
3. Chang K.S., Cai Z., Zhang C., Sen G.C., Williams B.R., and Luo G. Replication of hepatitis C virus (HCV) RNA in mouse embryonic fibroblasts: protein kinase R (PKR)-dependent and PKR-independent mechanisms for controlling HCV RNA replication and mediating interferon activities. J. Virol. 80 15 (2006) 7364-7374
4. Chen S.L., and Morgan T.R. The natural history of hepatitis C virus (HCV) infection. Int. J. Med. Sci. 3 2 (2006) 47-52
5. Chiu S.Y., Lejeune F., Ranganathan A.C., and Maquat L.E. The pioneer translation initiation complex is functionally distinct from but structurally overlaps with the steady-state translation initiation complex. Genes Dev. 18 7 (2004) 745-754
6. Choi S.Y., Scherer B.J., Schnier J., Davies M.V., Kaufman R.J., and Hershey J.W. Stimulation of protein synthesis in COS cells transfected with variants of the alpha-subunit of initiation factor eIF-2. J. Biol. Chem. 267 1 (1992) 286-293
7. Cuddihy A.R., Li S., Tam N.W., Wong A.H., Taya Y., Abraham N., Bell J.C., and Koromilas A.E. Double-stranded-RNA-activated protein kinase PKR enhances transcriptional activation by tumor suppressor p53. Mol. Cell. Biol. 19 4 (1999) 2475-2484
8. Davis S., and Watson J.C. In vitro activation of the interferon-induced, double-stranded RNA-dependent protein kinase PKR by RNA from the 3′ untranslated regions of human alpha-tropomyosin. Proc. Natl. Acad. Sci. U.S.A. 93 1 (1996) 508-513
9. Delhem N., Sabile A., Gajardo R., Podevin P., Abadie A., Blaton M.A., Kremsdorf D., Beretta L., and Brechot C. Activation of the interferon-inducible protein kinase PKR by hepatocellular carcinoma derived-hepatitis C virus core protein. Oncogene 20 41 (2001) 5836-5845
10. Gale Jr. M., Blakely C.M., Kwieciszewski B., Tan S.L., Dossett M., Tang N.M., Korth M.J., Polyak S.J., Gretch D.R., and Katze M.G. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol. Cell. Biol. 18 9 (1998) 5208-5218
11. Goh K.C., deVeer M.J., and Williams B.R. The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin. EMBO J. 19 16 (2000) 4292-4297
12. Hiasa Y., Kamegaya Y., Nuriya H., Onji M., Kohara M., Schmidt E.V., and Chung R.T. Protein kinase R is increased and is functional in hepatitis C virus-related hepatocellular carcinoma. Am. J. Gastroenterol. 98 11 (2003) 2528-2534
13. Itsui Y., Sakamoto N., Kurosaki M., Kanazawa N., Tanabe Y., Koyama T., Takeda Y., Nakagawa M., Kakinuma S., Sekine Y., Maekawa S., Enomoto N., and Watanabe M. Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication. J. Viral. Hepatitis 13 10 (2006) 690-700
14. Katze M.G., Wambach M., Wong M.L., Garfinkel M., Meurs E., Chong K., Williams B.R., Hovanessian A.G., and Barber G.N. Functional expression and RNA binding analysis of the interferon-induced, double-stranded RNA-activated, 68, 000-Mr protein kinase in a cell-free system. Mol. Cell. Biol. 11 11 (1991) 5497-5505
15. Kumar A., Yang Y.L., Flati V., Der S., Kadereit S., Deb A., Haque J., Reis L., Weissmann C., and Williams B.R. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB. EMBO J. 16 2 (1997) 406-416
16. Lancaster A.M., Jan E., and Sarnow P. Initiation factor-independent translation mediated by the hepatitis C virus internal ribosome entry site. RNA 12 5 (2006) 894-902
17. Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., Maruyama T., Hynes R.O., Burton D.R., McKeating J.A., and Rice C.M. Complete replication of hepatitis C virus in cell culture. Science 309 5734 (2005) 623-626
18. Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., and Tschopp J. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437 7062 (2005) 1167-1172
19. National Institutes of Health Consensus Panel, 2002. National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: June 10-12, 2002. Hepatology 36 (5 Suppl. 1), S3-S20.
20. Noguchi T., Satoh S., Noshi T., Hatada E., Fukuda R., Kawai A., Ikeda S., Hijikata M., and Shimotohno K. Effects of mutation in hepatitis C virus nonstructural protein 5A on interferon resistance mediated by inhibition of PKR kinase activity in mammalian cells. Microbiol. Immunol. 45 12 (2001) 829-840
21. Reed L.J., and Muench H. A simple method for estimating fifty percent endpoints. Am. J. Hyg. 27 (1938) 493-497
22. Rivas-Estilla A.M., Svitkin Y., Lopez Lastra M., Hatzoglou M., Sherker A., and Koromilas A.E. PKR-dependent mechanisms of gene expression from a subgenomic hepatitis C virus clone. J. Virol. 76 21 (2002) 10637-10653
23. Robert F., Kapp L.D., Khan S.N., Acker M.G., Kolitz S., Kazemi S., Kaufman R.J., Merrick W.C., Koromilas A.E., Lorsch J.R., and Pelletier J. Initiation of protein synthesis by hepatitis C virus is refractory to reduced eIF2.GTP.Met-tRNA(i)(Met) ternary complex availability. Mol. Biol. Cell. 17 11 (2006) 4632-4644
24. Sen G.C., and Ransohoff R.M. Interferon-induced antiviral actions and their regulation. Adv. Virus Res. 42 (1993) 57-102
25. Taylor D.R., Shi S.T., Romano P.R., Barber G.N., and Lai M.M. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285 5424 (1999) 107-110
26. Terenin I.M., Dmitriev S.E., Andreev D.E., and Shatsky I.N. Eukaryotic translation initiation machinery can operate in a bacterial-like mode without eIF2. Nat. Struct. Mol. Biol. 15 8 (2008) 836-841
27. Thomis D.C., and Samuel C.E. Mechanism of interferon action: autoregulation of RNA-dependent P1/eIF-2 alpha protein kinase (PKR) expression in transfected mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 89 22 (1992) 10837-10841
28. Tokumoto Y., Hiasa Y., Horiike N., Michitaka K., Matsuura B., Chung R.T., and Onji M. Hepatitis C virus expression and interferon antiviral action is dependent on PKR expression. J. Med. Virol. 79 8 (2007) 1120-1127
29. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Krausslich H.G., Mizokami M., Bartenschlager R., and Liang T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11 7 (2005) 791-796
30. Wang C., Pflugheber J., Sumpter Jr. R., Sodora D.L., Hui D., Sen G.C., and Gale Jr. M. Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication. J. Virol. 77 7 (2003) 3898-3912
31. Williams B.R. PKR; a sentinel kinase for cellular stress. Oncogene 18 45 (1999) 6112-6120
32. Yu S.H., Nagayama K., Enomoto N., Izumi N., Marumo F., and Sato C. Intrahepatic mRNA expression of interferon-inducible antiviral genes in liver diseases: dsRNA-dependent protein kinase overexpression and RNase L inhibitor suppression in chronic hepatitis C. Hepatology 32 5 (2000) 1089-1095
33. Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D.R., Wieland S.F., Uprichard S.L., Wakita T., and Chisari F.V. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. U.S.A. 102 26 (2005) 9294-9299